By: Daniel Trecroci
Blood-glucose meter maker LifeScan agreed on November 26, 2001, to pay $45 million to hundreds of thousands of people with diabetes—avoiding a trial that was set to begin that week.
According to Howard Mintz of the San Jose Mercury News, the settlement resolved a nationwide class-action lawsuit filed on behalf of consumers who purchased LifeScan’s SureStep blood-glucose meter. In 2000, LifeScan pleaded guilty to misdemeanor charges involving defects in the SureStep meter that it allegedly knew about but failed to disclose to consumers or to the U.S. Food and Drug Administration.
Under the conditions of the settlement, LifeScan admits no wrongdoing. “In the past, LifeScan, while conceding that it made mistakes, has strongly denied intentionally marketing a defective product and causing any harm to people with diabetes who used the SureStep device, which has been upgraded and remains on the market,” according to the Mercury News article.
The settlement was announced in San Jose Federal Court.